Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.
2.

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD.

Calverley PM, Eriksson G, Jenkins CR, Anzueto AR, Make BJ, Persson A, Fagerås M, Postma DS.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 19;12:13-25. doi: 10.2147/COPD.S114209. eCollection 2017.

3.
4.

Insight into Best Variables for COPD Case Identification: A Random Forests Analysis.

Leidy NK, Malley KG, Steenrod AW, Mannino DM, Make BJ, Bowler RP, Thomashow BM, Barr RG, Rennard SI, Houfek JF, Yawn BP, Han MK, Meldrum CA, Bacci ED, Walsh JW, Martinez F.

Chronic Obstr Pulm Dis. 2016;3(1):406-418.

5.

Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.

Han MK, Steenrod AW, Bacci ED, Leidy NK, Mannino DM, Thomashow BM, Barr RG, Make BJ, Bowler RP, Rennard SI, Houfek JF, Yawn BP, Meldrum CA, Walsh JW, Martinez FJ.

Chronic Obstr Pulm Dis. 2015;2(2):103-121.

6.

Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population.

Leidy NK, Kim K, Bacci ED, Yawn BP, Mannino DM, Thomashow BM, Barr RG, Rennard SI, Houfek JF, Han MK, Meldrum CA, Make BJ, Bowler RP, Steenrod AW, Murray LT, Walsh JW, Martinez F; High-Risk-COPD Screening Study Group..

NPJ Prim Care Respir Med. 2015 Apr 16;25:15024. doi: 10.1038/npjpcrm.2015.24.

7.

TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.

Jordan RE, Adab P, Jowett S, Marsh JL, Riley RD, Enocson A, Miller MR, Cooper BG, Turner AM, Ayres JG, Cheng KK, Jolly K, Stockley RA, Greenfield S, Siebert S, Daley A, Fitzmaurice DA.

BMC Pulm Med. 2014 Oct 4;14:157. doi: 10.1186/1471-2466-14-157.

8.

Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy.

Corhay JL, Dang DN, Van Cauwenberge H, Louis R.

Int J Chron Obstruct Pulmon Dis. 2014;9:27-39. doi: 10.2147/COPD.S52012. Epub 2013 Dec 16. Review.

9.

Ten years of tiotropium: clinical impact and patient perspectives.

Yohannes AM, Connolly MJ, Hanania NA.

Int J Chron Obstruct Pulmon Dis. 2013;8:117-25. doi: 10.2147/COPD.S28576. Epub 2013 Mar 15. Review.

10.

Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

COPD Working Group..

Ont Health Technol Assess Ser. 2012;12(7):1-64. Epub 2012 Mar 1. Review. No abstract available.

11.

The feasibility and validity of a remote pulse oximetry system for pulmonary rehabilitation: a pilot study.

Tang J, Mandrusiak A, Russell T.

Int J Telemed Appl. 2012;2012:798791. doi: 10.1155/2012/798791. Epub 2012 Sep 24.

12.

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis.

Mills EJ, Druyts E, Ghement I, Puhan MA.

Clin Epidemiol. 2011 Mar 28;3:107-29. doi: 10.2147/CLEP.S16235.

13.

Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.

Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B.

BMC Health Serv Res. 2011 Feb 23;11:43. doi: 10.1186/1472-6963-11-43.

14.

Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach.

Jordan RE, Lam KB, Cheng KK, Miller MR, Marsh JL, Ayres JG, Fitzmaurice D, Adab P.

Thorax. 2010 Jun;65(6):492-8. doi: 10.1136/thx.2009.129395.

15.

Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD.

Seaman J, Leonard AC, Panos RJ.

Int J Chron Obstruct Pulmon Dis. 2010 Apr 7;5:89-97.

16.

Treatment of mild chronic obstructive pulmonary disease.

Chee A, Sin DD.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):563-73. Review.

17.

The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations.

Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA.

J Gen Intern Med. 2009 Apr;24(4):457-63. doi: 10.1007/s11606-009-0907-y. Epub 2009 Feb 5.

18.

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG.

BMC Med. 2009 Jan 14;7:2. doi: 10.1186/1741-7015-7-2.

19.

Chronic obstructive pulmonary disease: a view from the NHLBI.

Punturieri A, Croxton TL, Weinmann GG, Kiley JP.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):441-3. doi: 10.1164/rccm.200807-1128OE. No abstract available.

Supplemental Content

Support Center